Protective Effect of Halofuginone on Liver of Rat with Liver Fibrosis and Exploration of Its Mechanism
Wei Li,Huiling Fu,Zhaohui Wang,Bei Zhang
DOI: https://doi.org/10.13417/j.gab.036.002241
2017-01-01
Genomics and Applied Biology
Abstract:We randomly divided 75 cases of Wistar healthy rats into the control group,high dose group,middle dose group and low dose group with halofuginone,as well as the model group,with 15 rats in each group.We adopted tail vein injection of ConA to make model for the model group and the halofuginone groups with high,middle and low dose,while gave the control group with tail vein injection of phosphate buffer solution (PBS).The haloguginone groups with high,middle and low dose were respectively given a dose of 15 mg/kg,10 mg/kg,and 5 mg/kg ofhalofuginone mixed in feed,while the control group and the model group were given common feeding.The intervention time was 8 weeks,after which we determined relevant indicators of rat liver function in each group,then the rats were put to death.We observed the changes of liver histopathology of the groups as well as comparing the liver indexes and degrees of liver fibrosis.We used reverse transcription polymerase chain reaction (RT-PCR) to detect the expression of transforming growth factor-β1 (TGF-β1),matrix metalloproteinase-2 (MMP-2) mRNA and matrix metalloproteinase-9 (MMP-9) mRNA,and then analyzed the function mechanism of halofuginone on rats with liver fibrosis.The levels of serum AST,ALT,TP,TGF-β1,liver indexes,and the expressions of TGF-β1 mRNA in the halofuginone groups and the model group were far higher than those in the control group (p＜0.05),while the data above in the halofuginone groups were far lower than those in the model group (p＜0.05),among which the levels in the high dose group with halofuginone were far below those in the middle dose and low dose groups (p ＜0.05).The levels of serum ALB,MMP-2 and MMP-9,and the relative expressions of MMP-2 mRNA and MMP-9 mRNA in the halofuginone groups and the model group were obviously lower than those in the control group (p＜0.05),while these data in the halofuginone groups were significantly higher than those in the model group (p ＜0.05),and the levels in the high dose group of halofuginone were apparently higher than those in the middle dose and low dose groups (p＜0.05).The SSS scores in the halofuginone groups were evidently lower than those in the model group (p＜0.05),and the data in the high dose group of halofuginone was significantly lower than those in the middle dose and low dose groups (p ＜0.05).This study showed that the application of high dose ofhalofuginone in rats would clearly improve rats liver function and the degrees of liver fibrosis induced by ConA,and we speculated that it might be related to the inhibition of TGF-β1 mRN,and the increasing expressions ofMMP-2 mRNA and MMP-9 mRNA.